Market by Procedure (Laparoscopy, Orthopedic Surgery, Cardiovascular, Obstetrics and Gynecology, Wound Closure, Plastic & Reconstructive Surgery, Thoracic Surgery, Microvascular, Urology, Neurosurgery, Other Procedures) Type of Infection (Superficial Incisional SSI, Deep Incisional SSI, Organ or Space SSI) Industry Vertical (Hospitals, Ambulatory Surgical Centers) Product (Disinfectants, Manual Reprocessors Solutions, Surgical Drapes, Surgical Gloves, Skin Preparation Solutions, Surgical Irrigation, Surgical Scrubs, Hair Clippers, Medical Nonwovens, Other Products) and Country Outlook | Forecast 2024-2032
Triton’s analysis suggests that the Europe surgical site infection control market is estimated to progress in terms of revenue at a CAGR of 5.16% during the 2024-2032 forecast period.
Report scope can be customized per your requirements - Request Free Sample Report
The surgical site infection control market in Europe has been experiencing significant growth owing to increased awareness and stringent regulations around infection prevention. The European Centre for Disease Prevention and Control (ECDC) reports that the occurrence of surgical site infections (SSIs) ranged from 0.6% in knee prosthesis surgeries to 9.5% in open colon surgeries, depending on the type of procedure. The ECDC’s report also highlighted that European healthcare systems have been focusing on enhancing infection control measures, supported by initiatives such as the ‘Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI),’ which promotes best practices across EU member states.
Additionally, the implementation of advanced sterilization techniques, the use of antimicrobial sutures, and the adoption of real-time monitoring systems in hospitals have significantly fueled market growth. The rising healthcare expenditure and the European Union’s strict regulatory framework for hospital hygiene are also driving the expansion of the surgical site infection control market.
The countries reviewed in this region comprise:
The United Kingdom leads with the major market share, obtaining around $265.6 million in 2023
In 17 different surgical categories,1,122 surgical site infections were identified during the hospital stay or upon readmission during 2022-2023, as per a report by the UK Health Security Agency.
The UK has seen a concerted effort to reduce these infections, given their association with prolonged hospital stays, increased morbidity, and higher healthcare costs. These concerns drive the demand for better infection control measures, thereby contributing to the market’s growth.
The National Health Service (NHS) and related bodies have increased funding for research into infection control technologies, including advanced wound dressings, antiseptic solutions, and surgical techniques. This pushes healthcare providers to adopt advanced SSI control products and technologies, fueling market development.
Market Forecast for Germany
The surgical site infection control market in Germany is supported by increasing awareness and stringent regulations aimed at reducing healthcare-associated infections. The nation has seen an uptick in demand for advanced infection control products, such as antimicrobial dressings, sterilization equipment, and infection-resistant surgical tools. The German Society for Hospital Hygiene has been instrumental in promoting best practices for infection prevention. This focus on infection control is reflected in the German healthcare sector’s increased investment in modern technologies and training programs designed to minimize the risk of SSIs, enhancing overall patient safety and surgical outcomes.
The market is branched into type of infection, procedure, industry vertical, and product. Based on the type of infection, it is divided into superficial, deep incisional, and organ or space SSI.
Surgical site infections (SSIs) are a common complication in gastrointestinal surgeries, particularly influenced by the type of surgery and wound closure methods used. Among these, superficial incisional SSIs are the most frequent, occurring at the incision site on the skin and often leading to pus formation. They can be classified into two types: primary, which occurs at the main incision site, such as in a C-section, and secondary, which arises at an additional incision site, like a donor site in coronary artery bypass graft surgery.
Contender Analysis in the Surgical Site Infection Control Market:
BioMérieux SA offers a range of solutions and products for diagnosing and managing infectious diseases, cardiovascular conditions, and specific cancers. Its services also include microbial flora analysis, detection of pathogenic bacteria, air and surface quality monitoring, etc. In the healthcare sector, it supports medical clinics, hospitals, pharmaceutical companies, dental and orthodontic professionals, and health information systems. The company operates through subsidiaries and an extensive network of distributors. It is headquartered in Marcy l’Étoile, France.
In January 2024, the company acquired LUMED, a software firm specializing in clinical decision support systems. LUMED’s technology assists hospitals in optimizing antimicrobial prescriptions and tracking healthcare-associated infections.
Other major companies in the market are 3M, Ansell Limited, Johnson & Johnson, Kimberly-Clark Corporation, and Stryker Corporation.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the surgical site infection control market revenue growth in Europe and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the Europe surgical site infection control market’s growth during the upcoming years
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT
ANALYSIS ON THE SURGICAL SITE INFECTION CONTROL MARKET
2.1.1. COVID-19
IMPACT
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. KEY
MARKET STRATEGIES
2.3.1. PRODUCT
LAUNCHES
2.3.2. ACQUISITIONS
2.3.3. BUSINESS
DIVESTITURES & EXPANSIONS
2.4. MARKET
DRIVERS
2.4.1. ESCALATING
INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
2.4.2. GROWING
GERIATRIC POPULATION
2.4.3. REGULATORY
GUIDELINES FOR PREVENTING HOSPITAL-ACQUIRED INFECTION
2.5. MARKET
CHALLENGES
2.5.1. INCREASE
IN OUTPATIENT TREATMENT
2.5.2. SURGE
IN MEDICAL WASTE DUE TO THE USE OF DISPOSABLE MEDICAL ITEMS
2.5.3. INSUFFICIENT
AWARENESS REGARDING HOSPITAL-ACQUIRED INFECTIONS
2.6. MARKET
OPPORTUNITIES
2.6.1. GROWTH
OF MINIMALLY INVASIVE AND OUTPATIENT SURGICAL PRACTICES
2.6.2. RISE
IN SURGICAL PROCEDURE RATES
2.6.3. TECHNOLOGICAL
ADVANCEMENTS IN PREVENTING SURGICAL SITE INFECTIONS
2.7. ANALYST
PERSPECTIVE
3. EUROPE
SURGICAL SITE INFECTION CONTROL MARKET – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC
SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS
AND GYNECOLOGY
3.5. WOUND
CLOSURE
3.6. PLASTIC
& RECONSTRUCTIVE SURGERY
3.7. THORACIC
SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER
PROCEDURES
4. EUROPE
SURGICAL SITE INFECTION CONTROL MARKET – BY TYPE OF INFECTION
4.1. SUPERFICIAL
INCISIONAL SSI
4.2. DEEP
INCISIONAL SSI
4.3. ORGAN
OR SPACE SSI
5. EUROPE
SURGICAL SITE INFECTION CONTROL MARKET – BY INDUSTRY VERTICAL
5.1. HOSPITALS
5.2. AMBULATORY
SURGICAL CENTERS
6. EUROPE
SURGICAL SITE INFECTION CONTROL MARKET – BY PRODUCT
6.1. DISINFECTANTS
6.1.1. SKIN
DISINFECTANTS
6.1.2. HAND
DISINFECTANTS
6.2. MANUAL
REPROCESSORS SOLUTIONS
6.3. SURGICAL
DRAPES
6.4. SURGICAL
GLOVES
6.5. SKIN
PREPARATION SOLUTIONS
6.6. SURGICAL
IRRIGATION
6.7. SURGICAL
SCRUBS
6.8. HAIR
CLIPPERS
6.9. MEDICAL
NONWOVENS
6.10. OTHER
PRODUCTS
7. EUROPE
SURGICAL SITE INFECTION CONTROL MARKET – BY COUNTRY OUTLOOK
7.1. EUROPE
7.1.1. COUNTRY
ANALYSIS
7.1.1.1. UNITED
KINGDOM
7.1.1.1.1. UNITED
KINGDOM SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.1.2. GERMANY
7.1.1.2.1. GERMANY
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.1.3. FRANCE
7.1.1.3.1. FRANCE
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.1.4. SPAIN
7.1.1.4.1. SPAIN SURGICAL
SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.1.5. ITALY
7.1.1.5.1. ITALY SURGICAL
SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.1.6. THE NETHERLANDS
7.1.1.6.1. THE NETHERLANDS
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.1.7. REST
OF EUROPE
7.1.1.7.1. REST
OF EUROPE SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. AMERICAN
POLYFILM INC
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. 3M
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. ANSELL
LIMITED
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. BELIMED
LIFE SCIENCE AG
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. BECTON,
DICKINSON AND COMPANY (BD)
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. BIOMERIEUX
SA
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. GETINGE
AB
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. GAMA
HEALTHCARE
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. JOHNSON
& JOHNSON
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. SOTERA
HEALTH LLC
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. KIMBERLY-CLARK
CORPORATION
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY
STRENGTHS
8.11.4. KEY
CHALLENGES
8.12. STERIS
CORPORATION
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY
STRENGTHS
8.12.4. KEY
CHALLENGES
8.13. STRYKER
CORPORATION
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY
STRENGTHS
8.13.4. KEY
CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 2: LIST OF PRODUCT
LAUNCHES
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF BUSINESS
DIVESTITURES & EXPANSIONS
TABLE 5: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 6: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 7: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 8: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY PROCEDURE, 2023 & 2032 (IN %)
FIGURE 3: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2024-2032 (IN $ MILLION)
FIGURE 4: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 5: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 6: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2024-2032 (IN $
MILLION)
FIGURE 7: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2024-2032 (IN $ MILLION)
FIGURE 8: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2024-2032
(IN $ MILLION)
FIGURE 9: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 10: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 11: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY UROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 12: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2024-2032 (IN $ MILLION)
FIGURE 13: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2024-2032 (IN $
MILLION)
FIGURE 14: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2023 & 2032 (IN %)
FIGURE 15: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2024-2032 (IN $
MILLION)
FIGURE 16: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 17: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2024-2032 (IN $ MILLION)
FIGURE 18: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2023 & 2032 (IN %)
FIGURE 19: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 20: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $
MILLION)
FIGURE 21: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY PRODUCT, 2023 & 2032 (IN %)
FIGURE 22: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 23: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2023 & 2032 (IN %)
FIGURE 24: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY SKIN DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 25: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY HAND DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 26: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTIONS, 2024-2032 (IN
$ MILLION)
FIGURE 27: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2024-2032 (IN $ MILLION)
FIGURE 28: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2024-2032 (IN $ MILLION)
FIGURE 29: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTIONS, 2024-2032 (IN $
MILLION)
FIGURE 30: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2024-2032 (IN $ MILLION)
FIGURE 31: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2024-2032 (IN $ MILLION)
FIGURE 32: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2024-2032 (IN $ MILLION)
FIGURE 33: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2024-2032 (IN $ MILLION)
FIGURE 34: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 35: EUROPE SURGICAL
SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE 36: UNITED KINGDOM
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 37: GERMANY SURGICAL
SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 38: FRANCE SURGICAL
SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 39: ITALY SURGICAL SITE
INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 40: SPAIN SURGICAL SITE
INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 41: THE NETHERLANDS
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 42: REST OF EUROPE
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)